Literature DB >> 6994634

Boron-containing antibacterial agents: effects on growth and morphology of bacteria under various culture conditions.

P J Bailey, G Cousins, G A Snow, A J White.   

Abstract

The effects of a number of synthetic antibacterial agents of the borinic acid and diazaborine types on the growth of enteric bacteria were examined. In minimal medium aerobic growth was immediately slowed; slow nonexponential growth continued for an extended period, and the cells remained viable. The effect was also seen in anaerobic cultures and was not antagonized by a number of common nutrients, vitamins, or growth factors. The response was modified by the addition of casein hydrolysate to the medium. This seemed to be a nutritional effect dependent principally on lysine and leucine. The modified response consisted of a period of abnormal growth lasting for at least one doubling time after the addition of the antibacterial agent. The turbidity at first increased more rapidly than that of the controls and was approximately equal to that of the controls after 30 min. However, the increase in bacterial mass (dry weight) was only 0.75 of the amount predicted by the change in turbidity. The viable count increased in proportion to the turbidity. Changes in the cell envelope were revealed by electron microscopy and by an alteration in the response of cells to lytic agents. After the period of abnormal growth cultures entered a premature stationary phase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994634      PMCID: PMC283830          DOI: 10.1128/AAC.17.4.549

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Studies of the bacterial cell wall. II. Methods of preparation and some properties of cell walls.

Authors:  M R J SALTON; R W HORNE
Journal:  Biochim Biophys Acta       Date:  1951-07

2.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

3.  Antibacterial borazaro derivatives. I. 5-Arylsulphonyl-4-hydroxy-4,5-borazarothieno(2,3-c)pyridines and 6-arylsulphonyl-7-hydroxy-7,6-borazarothieno(3,2-c)pyridines.

Authors:  S Gronowitz; T Dahlgren; J Namtvedt; C Roos; B Sjöberg; U Forsgren
Journal:  Acta Pharm Suec       Date:  1971-09

4.  Antibacterial borazaro derivatives. II. Effect of substituents on the antibacterial activity of 5-arylsulphonyl-4-hydroxy-4,5-borazarothieno(2,3-c)pyridines and 6-arylsulphonyl-7-hydroxy-7,6-borazarothieno(3,2-c)pyridines.

Authors:  S Gronowitz; T Dahlgren; J Namtvedt; C Roos; G Rosén; B Sjöberg; U Forsgren
Journal:  Acta Pharm Suec       Date:  1971-12
  4 in total
  5 in total

1.  A Comparison of the Structure and Bonding in the Aliphatic Boronic R-B(OH)2 and Borinic R-BH(OH) acids (R=H; NH2, OH, and F): A Computational Investigation.

Authors:  Niny Z Rao; Joseph D Larkin; Charles W Bock
Journal:  Struct Chem       Date:  2015-12-30       Impact factor: 1.887

Review 2.  Boron chemicals in diagnosis and therapeutics.

Authors:  Bhaskar C Das; Pritam Thapa; Radha Karki; Caroline Schinke; Sasmita Das; Suman Kambhampati; Sushanta K Banerjee; Peter Van Veldhuizen; Amit Verma; Louis M Weiss; Todd Evans
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

3.  Antibacterial activity and mode of action of potassium tetraborate tetrahydrate against soft-rot bacterial plant pathogens.

Authors:  Yingyu Liu; Melanie J Filiatrault
Journal:  Microbiology (Reading)       Date:  2020-07-08       Impact factor: 2.777

4.  Ion Release From Prototype Surface Pre-Reacted Glass Ionomer (S-PRG) Sealer and EndoSequence BC Sealer.

Authors:  Aparna Bhat; Nicholas Cvach; Cassia Mizuno; Chul Ahn; Qiang Zhu; Carolyn Primus; Takashi Komabayashi
Journal:  Eur Endod J       Date:  2021-03-08

Review 5.  The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry.

Authors:  Katia Messner; Billy Vuong; Geoffrey K Tranmer
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.